Modified Bromelain-Rx - Anatara Lifesciences

Drug Profile

Modified Bromelain-Rx - Anatara Lifesciences

Alternative Names: Detach™

Latest Information Update: 07 Oct 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Anatara Lifesciences
  • Class Anti-inflammatories; Antidiarrhoeals; Cysteine endopeptidases; Skin disorder therapies
  • Mechanism of Action Bacterial growth inhibitors; Inflammation mediator inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase I Diarrhoea

Most Recent Events

  • 07 Oct 2016 Modified Bromelain-Rx is available for licensing as of 07 Oct 2016.
  • 07 Oct 2016 Phase-I clinical trials in Diarrhoea in Australia (unspecified route) prior to October 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top